Shorter course of radiation for breast cancer offers patients important benefit
the ONA take:
Researchers at the University of Texas MD Anderson Cancer Center report that a shorter course of whole breast radiation therapy for early stage breast cancer results in less toxicity and improved quality of life compared with a longer course of treatment.
They believe this information should be included in shared decision-making discussions with breast cancer patients.
Radiation treatment historically is given in smaller doses over a longer period of time (conventionally fractionated whole breast irradiation [CF-WBI]), rather than higher doses of radiation administered over a shorter time period (hypofractionated whole breast irradiation [HF-WBI]).
Older studies on the shorter treatment times produced disappointing results; however, the technology used in those studies is now antiquated.
With the use of modern technology, recurrence outcomes and survival rates are now equal yet use of the shorter treatment is slow to catch on.
Participants in the study reported less difficulty in managing their families’ needs, which is a major priority for many women.
The researchers believe their study demonstrates that HF-WBI is not just an option for patients; it should be considered as a preferred starting point in discussions with patients who need whole breast radiation. In addition, organizations such as ASTRO and NCCN should consider expanding their recommendations to include HF-WBI.
Shorter course of whole breast radiation therapy for early stage breast cancer results in less toxicity and improved quality of life.
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Including a PI3-Kinase Inhibitor with an PARP Inhibitor Improves Tumor Shrinkage in Patients with Resistant Ovarian Cancer
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Shifts in Cancer Burden for People With HIV Projected
- Tissue Biobank Procurement Consent Should Include Discussion of Confidentiality Risks
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|